MicroTransponder’s Vivistim® Procedure Gains Significant Medicare Payment Approval MicroTransponder's Vivistim® procedure receives a vital Medicare payment classification, facilitating better access for stroke recovery patients starting January 2026.

MicroTransponder’s Vivistim® Procedure Gains Significant Medicare Payment Approval #USA #Austin #Vivistim #MicroTransponder #VNS_Therapy

MicroTransponder Welcomes Dana G. Mead, Jr. as New Chair and Adds Cynthia Lucchese as Independent Director MicroTransponder, a leader in medical technology, announces the appointment of Dana G. Mead, Jr. as Chair and Cynthia Lucchese as Independent Director to enhance its strategic governance.

MicroTransponder Welcomes Dana G. Mead, Jr. as New Chair and Adds Cynthia Lucchese as Independent Director #United_States #healthcare #Austin #Vivistim #MicroTransponder

Navzer Engineer of MicroTransponder Honored as CNS Innovator of the Year for Vivistim Breakthrough Navzer Engineer, co-founder of MicroTransponder, earned the CNS Innovator of the Year Award for Vivistim, a device aiding stroke recovery. This achievement highlights advancements in medical technology.

Navzer Engineer of MicroTransponder Honored as CNS Innovator of the Year for Vivistim Breakthrough #United_States #Austin #Vivistim #MicroTransponder #Navzer_Engineer

Connecticut Launches $2 Million Center for Veterans' Stroke Recovery with Vivistim Therapy Connecticut has approved a $2 million center for veterans that provides access to the FDA-approved Vivistim therapy aiding stroke recovery.

Connecticut Launches $2 Million Center for Veterans' Stroke Recovery with Vivistim Therapy #United_States #Hartford #Stroke_Recovery #Vivistim #MicroTransponder

Long-Term Improvements for Chronic Stroke Survivors with Vivistim Therapy Highlighted in New Study Recent research shows that chronic stroke survivors experience sustained improvements in motor function following treatment with Vivistim therapy for over a year, enhancing quality of life.

Long-Term Improvements for Chronic Stroke Survivors with Vivistim Therapy Highlighted in New Study #USA #Austin #Stroke_Recovery #Vivistim #MicroTransponder

MicroTransponder Raises $65 Million for Vivistim's Stroke Rehabilitation Expansion MicroTransponder has secured $65 million in funding to accelerate the adoption of its Vivistim therapy, which enhances recovery for stroke survivors through innovative technology.

MicroTransponder Raises $65 Million for Vivistim's Stroke Rehabilitation Expansion #United_States #Austin #Stroke_Recovery #Vivistim #MicroTransponder

Innovative Vivistim Therapy Shows Promise for Stroke Recovery at ISC 2025 At the International Stroke Conference 2025, Dr. Ronald P. Benitez presents groundbreaking data on Vivistim therapy's success for stroke rehabilitation.

Innovative Vivistim Therapy Shows Promise for Stroke Recovery at ISC 2025 #United_States #Austin #Stroke_Recovery #Vivistim #MicroTransponder